|
SAPX, AONE, STEM, IDOI, ECDC, WTWO
Our Stocks to Watch today include Seven Arts Entertainment Inc. (Nasdaq: SAPX), A123 Systems Inc. (Nasdaq: AONE), StemCells Inc. (Nasdaq: STEM), IDO Security Inc. (OTC: IDOI), East Coast Diversified Corp. (OTC: ECDC) and W2 Energy Inc. (OTC: WTWO).
SEVEN ARTS ENTERTAINMENT INCORPORATED (NASDAQ: SAPX)
"Up 14.68% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/SAPX.php
Seven Arts Entertainment Inc. is the successor to Seven Arts Pictures Plc., which was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production, and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.
SAPX News:
July 12 - Seven Arts Entertainment Announces the US Theatrical Release of 'Drunkboat'
Seven Arts Entertainment Inc. (Nasdaq: SAPX) ("Seven Arts") announced the US theatrical release of "Drunkboat" (the "Film"). The film will be released on Friday, July 13th, exclusively through AMC Movie Theatres throughout major cities to include Chicago, Los Angeles, New York and Boston.
"Drunkboat" is the new tragi-comedy from playwright/director Bob Meyer, starring John Malkovich, John Goodman and Dana Delany. "Drunkboat" tells the story of Mort Gleason (Malkovich), who returns to the family home after a 25-year absence, where his sister (Delany) is raising her young son Abe. Abe is in the thrall of purchasing a sloop from an unscrupulous boat salesman (Goodman). Both powerful and touching, this film tells the story of a young man's dreams of sailing the world and an older man's reconciliation with his family.
Gabe Toro from IndieWire raves about the film, "It remains a pleasure to see, in Malkovich and Goodman, two canny pros at the top of their game".
"We are thrilled this picture will be released throughout the US and could not be more pleased to be working with AMC Theaters," said Peter Hoffman, CEO of Seven Arts. "This is a great movie that deserves to be shown to a wider audience."
Executive Producer Anthony Tomaska said, "Malkovich and Goodman are awesome together in this touching film."
A123 SYSTEMS INCORPORATED (NASDAQ: AONE)
"Up 9.60% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/AONE.php
A123 Systems, Inc. (AONE) is a leading developer and manufacturer of advanced lithium-ion batteries and energy storage systems for transportation, electric grid and commercial applications. The company's proprietary Nanophosphate(R) lithium iron phosphate technology is built on novel nanoscale materials initially developed at the Massachusetts Institute of Technology and is designed to deliver high power and energy density, increased safety and extended life. A123 leverages breakthrough technology, high-quality manufacturing and expert systems integration capabilities to deliver innovative solutions that enable customers to bring next-generation products to market.
AONE News:
June 12 - A123 Systems to Supply Energy Storage System to Ray Power for Frequency Regulation in China
System Designed to Showcase Lithium Ion Battery Energy Storage as a Fast, Accurate and Clean Resource for Facilitating the Increased Integration of Renewable Energy Generation onto China's Power Grid
A123 Systems (Nasdaq: AONE), a developer and manufacturer of advanced Nanophosphate(R) lithium iron phosphate batteries and systems, today announced that it will supply a 2MW grid energy storage system to Ray Power Systems Co. Ltd., a Chinese company focused on developing the frequency regulation market and relevant technologies.
"The project in China will be designed to validate the technical capabilities and benefits of energy storage as a fast-ramping, accurate and clean resource for providing frequency regulation services," said Eldon Mou, CEO of Ray Power. "Limited overall system ramping capability has created renewable integration issues as well as potential risk of grid instability because of the high penetration of renewable generation, particularly in northern China. A123 Systems has demonstrated the viability and reliability of its product through a number of successful global commercial deployments, and we expect this project to showcase energy storage as a valuable resource for meeting China's growing frequency regulation demand."
"We believe that China represents a large market opportunity for our energy storage technology, including as a solution to address the ramp-management challenges associated with the increased deployment of wind and other renewable energy generation assets," said Robert Johnson, vice president of the Energy Solutions Group at A123. "Today's announcement builds on our progress in China and is a significant step toward proving the capability of our technology for providing frequency regulation in China. Ray Power has a deep understanding of China's power market and of energy storage technologies and has developed a set of comprehensive solutions for deploying energy storage to capitalize on this growing opportunity, so we look forward to success in this initial deployment and believe it could lead to additional projects going forward."
STEMCELLS INCORPORATED (NASDAQ: STEM)
"Up 10.71% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/STEM.php
StemCells, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery. The Company's lead therapeutic product candidate, HuCNS-SC® cells (purified human neural stem cells), is currently in development as a potential treatment for a broad range of central nervous system disorders. In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, the Company has shown preliminary evidence of progressive and durable donor-derived myelination in all four patients transplanted with HuCNS-SC cells. The Company is also conducting a Phase I/II clinical trial in chronic spinal cord injury in Switzerland and recently reported positive interim safety data for the first patient cohort. The Company has also initiated a Phase I/II clinical trial in dry age-related macular degeneration (AMD), and is pursuing preclinical studies in Alzheimer's disease. StemCells also markets stem cell research products, including media and reagents, under the SC Proven® brand.
STEM News:
July 17 - StemCells, Inc. Announces Its Human Neural Stem Cells Restore Memory in Models of Alzheimer's Disease
StemCells, Inc. (Nasdaq: STEM) announced preclinical data demonstrating that its proprietary human neural stem cells restored memory and enhanced synaptic function in two animal models relevant to Alzheimer's disease (AD). The data was presented today at the Alzheimer's Association International Conference 2012 in Vancouver, Canada.
The study results showed that transplanting the cells into a specific region of the brain, the hippocampus, statistically increased memory in two different animal models. The hippocampus is critically important to the control of memory and is severely impacted by the pathology of AD. Specifically, hippocampal synaptic density is reduced in AD and correlates with memory loss. The researchers observed increased synaptic density and improved memory post transplantation. Importantly, these results did not require reduction in beta amyloid or tau that accumulate in the brains of patients with AD and account for the pathological hallmarks of the disease.
The research was conducted in collaboration with a world-renowned leader in AD, Frank LaFerla, Ph.D., Director of the University of California, Irvine (UCI) Institute for Memory Impairments and Neurological Disorders (UCI MIND), and Chancellor's Professor, Neurobiology and Behavior in the School of Biological Sciences at UCI. Matthew Blurton-Jones, Ph.D., Assistant Professor, Neurobiology and Behavior at UCI, presented the study results.
"This is the first time human neural stem cells have been shown to have a significant effect on memory," said Dr. LaFerla. "While AD is a diffuse disorder, the data suggest that transplanting these cells into the hippocampus might well benefit patients with Alzheimer's. We believe the outcomes in these two animal models provide strong rationale to study this approach in the clinic and we wish to thank the California Institute of Regenerative Medicine for the support it has given this promising research."
Stephen Huhn, M.D., FACS, FAAP, Vice President and Head of the CNS Program at StemCells, added, "While reducing beta amyloid and tau burden is a major focus in AD research, our data is intriguing because we obtained improved memory without a reduction in either of these pathologies. AD is a complex and challenging disorder. The field would benefit from the pursuit of a diverse range of treatment approaches and our neural stem cells now appear to offer a unique and viable contribution in the battle against this devastating disease."
ABOUT ALZHEIMER'S DISEASE
Alzheimer's disease is a progressive, fatal neurodegenerative disorder that results in loss of memory and cognitive function. Today there is no cure or effective treatment option for patients afflicted by Alzheimer's disease. According to the Alzheimer's Association, approximately 5.4 million Americans have Alzheimer's disease, including nearly half of people aged 85 and older. The prevalence of Alzheimer's disease is expected to increase rapidly as a result of the country's aging population.
IDO SECURITY INCORPORATED (OTCBB: IDOI)
"Up 14.10% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/IDOI.php
Headquartered in New York with a subsidiary in Israel, IDO Security designs, develops and markets the patented MagShoe™ shoe scanning device (SSD), filling a critical void in today's detectors by extending screening to the lower body and feet. MagShoe™'s "shoes-on" design maximizes security, thoroughness and accuracy while eliminating the need to remove shoes for increased convenience and safety; neither invasive nor harmful to the body as some of the other screening devices currently used in the marketplace. Ideal for security and loss prevention at virtually any facility, MagShoe™ is currently in use worldwide at international airports, cruise lines, government agencies, correctional facilities, mints and more.
IDOI News:
July 2 - IDO Security Resumes Full DTC Eligibility
DTC Chill Order Removed
IDO Security Inc. (OTCBB: IDOI), developer of the innovative MagShoe™ shoe scanning device (SSD), announced that the Depository Trust Company (DTC), has removed the "chill" status from IDO's stock. Effective June 29, 2012, the DTC restored electronic clearance and settlement services for the Company's "IDOI" security, enabling normal electronic trading of the shares. The Depository Trust Company is a member of the U.S. Federal Reserve System and a registered clearing agency with the Securities and Exchange Commission. It was established to provide a safe and efficient way for buyers and sellers of securities to execute and settle transactions.
"We are gratified that our stock is once again DTC eligible, which will now enable our stock to be traded freely among shareholders and the investment community in the market," commented Michael Goldberg, President of IDO Security. "We continue to make strides in improving the Company's capital structure and we look to a better and brighter future in building shareholder value as our flagship product, the MagShoe, continues to expand its market presence around the world."
EAST COAST DIVERSIFIED CORPORATION (OTCBB: ECDC)
"Up 41.18% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/ECDC.php
East Coast Diversified Corp. operates through its subsidiary, EarthSearch Communications, Inc. East Coast Diversified Corp. offers a portfolio of GPS devices, RFID interrogators, integrated GPS/RFID technologies and Tag designs. The company was founded in 2010 and is based in Atlanta, Georgia.
ECDC News:
July 19 - East Coast Diversified Management Will Host Investors Conference Call
East Coast Diversified Corporation (OTC: ECDC) announced the Company will host a conference call on Tuesday, July 31, 2012 at 11:00 a.m. Eastern Daylight Time to provide a shareholders update and discuss the Company's recent progress, the launching of its Social media and School transportation division, revenue growth, strong breakthrough into the US logistics market and future plans. "We are excited to discuss with our shareholders all the progress we have made and what we plan on for the future of this business," said Kayode Aladesuyi, ECDC CEO.
Conference Call Details:
Conference Date: Tuesday, July 31, 2012
Conference Start Time: 11:00AM Eastern Standard Time
Participant Dial-In Numbers:
TOLL-FREE 1-877-941-8418
TOLL/INTERNATIONAL 1-480-629-9809
W2 ENERGY INCORPORATED (OTC: WTWO)
"Up 36.84% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/WTWO.php
W2 Energy Inc. develops renewable energy technologies and applies it to new generation power systems. Specifically, W2 Energy's plasma assisted biomass to energy plants utilize state of the art technologies to produce green energy both fuel (sulfur free diesel) and electricity at the most efficient cost in capital investment and production per/barrel, per/Megawatt. W2 Energy Inc. has seasoned management, cutting edge technology and owns a large technology portfolio of patents and know-how that has been extensively validated and ready for commercial production.
WTWO News:
July 11 - W2 Energy Nears Final Stages of Completion for Its Newly Acquired Bio-Diesel Plant
Company Gives 3rd Quarter Update on Several Developments Near Completion
W2 Energy, Inc. (OTC: WTWO) announced that it is in the final stages of completion for its recently acquired Bio-diesel plant.
As previously reported, W2 Energy recently purchased a fully operating turn-key bio-diesel plant from Agri-Green Biodiesel, Inc. The plant was successfully transported to the Company's 23,000 sq. ft. manufacturing facility in Guelph, Ontario last month and is now near completion. W2 Energy expects to have the plant fully functional and operating by August 01, 2012.
Current expectations are for the production of approximately 650,000 gallons of bio-diesel per year with this plant which at today's current market value should be worth close to $3 million in revenues. Future plans for the plant will include a retrofit modification of the plant in order to increase its production by up to 1.2 million gallons per year. By increasing the productions capabilities the Company expects to be able to double its revenue capabilities.
Also, as previously reported, the Company recently announced a Joint Venture Partnership in Europe with W2H Luxembourg Holdings, LLC which included the development and manufacturing of a demo plant for Dubai and a purchase order for several custom-made combustion engines.
The demo plant is fully designed and proceeding on schedule. The plant will be utilizing its new state of the art liquid plasma torch technology. Currently, parts are out for manufacture and expectations are to have this unit ready for testing later this month.
Additionally, W2's new combustion engine is now fully designed and simulated. Parts are currently out for manufacture and expectations are to have this unit manufactured by mid-August. W2 is extremely happy with the final design and believes that this engine will become a pivotal product for the Company and will be the first product to generate significant revenue.
On April 04, 2012 W2 Energy announced plans for a state of the art Fischer-Tropsch laboratory facility in Catonsville, Maryland. The Company is pleased to announce they are currently in the final stages of securing the lab in Maryland and have hired Dr. Teiseh as an employee of W2 Energy. Dr. Teiseh received his PhD in Engineering from Texas A&M. His experience in both engineering and renewable energy will provide the expertise W2 is looking for with this type of facility. Dr. Teiseh has spent the last two months in preparation for the manufacturing and testing of W2's FT catalyst once the laboratory is ready.
On March 15, 2012, W2 Energy announced plans to develop 2 acres of recently acquired land in order to construct greenhouses for W2's patented Algae Bio-Reactors. The Company is now in the final stages of submitting their environmental impact study and all required surveys in order to begin land clearing and leveling for the proposed greenhouse structures and the next generation algae bio-reactors.
Mike McLaren, President and CEO of W2 Energy, stated, "This is a very exciting time for W2 Energy and its employees. Everything we are currently working on has been a culmination of years of hard work and sacrifice. We are extremely confident that this quarter will be the first time we will have the ability to produce a revenue stream which will take us out of the research and development stage category and place us in the manufacturing and production industry."
|
